Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer

PURPOSE: Pemetrexed-based chemotherapy (Pem-C) is the first-line chemotherapy for advanced non-squamous non-small cell lung cancer (NSCLC). However, limited tumor-associated proteins in blood are available to predict pemetrexed response and/or survival. PATIENTS AND METHODS: Plasma samples from thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Che-Hsing, Ko, Jiunn-Liang, Hsiao, Yu-Ping, Tsai, Ming-Hung, Lai, Yen-Chein, Hsin, I-Lun, Kang, Yu-Ting, Sheu, Gwo-Tarng, Lin, Wea-Lung, Wu, Ming-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866988/
https://www.ncbi.nlm.nih.gov/pubmed/35221721
http://dx.doi.org/10.2147/CMAR.S338957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866988/
https://www.ncbi.nlm.nih.gov/pubmed/35221721
http://dx.doi.org/10.2147/CMAR.S338957

Ejemplares similares